Topic Menu
► Topic MenuTopic Editors
Metal Coordination Complexes in Biological Systems
Topic Information
Dear Colleagues,
Metal complexes and inorganic salts are used for medicinal purposes since ancient times. Antimony was used by Assyrians for urinary tract afflictions. Antimony compounds were used in Europe from the Middle Ages until the nineteenth century as laxatives and “humor cleansers.” Today, antimony salts are employed against schistosomiasis and leishmaniasis. Other metal compounds currently used in medicine include gold(I) complexes such as aurothiomalate (Myocrisin), aurothioglucose (Solganol), aurothiopropanol sulfonate (Allochrysin), and the oral drug auranofin (Ridaura) for the treatment of difficult cases of rheumatoid arthritis (37), bismuth subcitrate, and subsalicylate are for the treatment of diarrhea, dyspepsia and gastric ulcers, and the world-famous cisplatin for cancer chemotherapy.
Metal complexes are less abundant medicines than the purely organic small molecules, mainly due to the difficulty in establishing high-throughput screening and synthesis methods for their preparation and evaluation, in addition to the higher cost of production of molecules incorporating one or more metal atoms. Nevertheless, metal complexes have been continuously and increasingly investigated as promising sources of innovative drugs for challenging pathologies such as cancer, metabolic diseases, microbial infection, and neglected tropical diseases.
The topic “Metal Coordination Complexes in Medicine” welcomes contributions that describe interesting advances in the field or identify new targets for metals in biological systems. The submitted papers can encompass both research articles and critical reviews, the latter of which is expected to direct readers to new avenues of research in metal drug development.
Dr. Susana Santos Braga
Dr. Filipe Alexandre Almeida Paz
Topic Editors
Keywords
- metal antitumorals
- metal-based biocides
- antiparasitic agents
- oligoelements
- metal-organic frameworks (MOFs)
- BioMOFs
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
|---|---|---|---|---|---|
Applied Sciences
|
2.5 | 5.3 | 2011 | 18.4 Days | CHF 2400 |
Bioengineering
|
3.8 | 4.0 | 2014 | 16.4 Days | CHF 2700 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
